Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Essential prescribing information format outlined in draft labeling guidance.

This article was originally published in The Gray Sheet

Executive Summary

ESSENTIAL PRESCRIBING INFORMATION FORMAT OUTLINED IN FDA LABELING GUIDANCE draft dated April 15. The goal of a one-page essential prescribing information (EPI) format in device labeling is "to provide an overview and a refresher for those already familiar with the full labeling" and communicate "more effectively with practitioners and users of medical devices" the key elements in device labeling, the agency's Center for Devices and Radiological Health says in the draft guidance.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT007954

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel